CNS Pharmaceuticals Inc.

2.20
-0.23 (-9.47%)
At close: Mar 03, 2025, 3:59 PM
2.20
0.00%
After-hours: Mar 03, 2025, 04:41 PM EST

CNS Pharmaceuticals Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -12.63 -10.7K -61.78K -155.27K -837.89K -508.48K -7.14M
PEG Ratio 0.23 312.58 74.3K -1.08K 17.62K -389.93 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio -53.73 20.09K 135.24K 105.28K 427.4K -6.84M -64.21M
P/FCF Ratio -16.84 -15.47K -66.12K -200.18K -909.08K -5.25M -33.5M
P/OCF Ratio -16.84 -15.48K -66.15K -200.67K -914.23K -5.25M -33.5M
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -0.07 0.05 0.06 0.03 n/a -0.58 -2.08
Quick Ratio 0.26 2.55 3.50 8.13 25.38 0.48 0.73
Current Ratio 0.26 2.55 3.50 8.13 25.38 0.48 0.73
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -2.17K -1.51K -2.9K -86.65 -18.88 n/a
Return on Equity (ROE) 4.25 -1.88 -2.19 -0.68 -0.51 13.46 8.99
Return on Assets (ROA) -11.08 -1.17 -1.66 -0.6 -0.49 -10.82 -3.25
Return on Capital (ROIC) 4.26 -1.88 -2.12 -0.68 -0.5 1.61 3.67
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a